comparemela.com

Latest Breaking News On - Tl praveen kumar - Page 2 : comparemela.com

Centre Gives Sanction To Prosecute Joint Drugs Controller In Bribery Case

The government has granted the sanction to prosecute Central Drugs Standard Control Organisation's joint drugs controller S Eswara Reddy, clearing the decks for initiating a trial against him for allegedly taking a bribe to favourably recommend Biocon Biologics' insulin injection, officials said Sunday.

India
Canada
Japan
United-states
Dinesh-dua
Biocon-biologics
Guljit-sethi
S-eswara-reddy
Tl-praveen-kumar
Animesh-kumar
Centre-gives-sanction-to-prosecute-joint-drugs
Union-ministry-for-health

Gold loan scam: ED chargesheets 6 before PMLA court

The Enforcement Directorate (ED) on Thursday filed a prosecution complaint (charge sheet) against six people before a Special PMLA court in Bengaluru in connection with a money laundering case pertaining to gold loan scam.Those charge-sheeted .

Baroda
Gujarat
India
Bengaluru
Karnataka
New-delhi
Delhi
Lnarasimha-murthy
Vasantha-kumari
Sk-subramanaya-reddy
Tl-praveen-kumar
Corruption-branch

India News | Delhi HC Grants Bail to Joint Drug Controller of CDSCO

Get latest articles and stories on India at LatestLY. The Delhi High Court on Tuesday granted bail to the Joint Drug Controller of the Central Drugs Standard Control Organisation (CDSCO) and a Biocon Biologics executive in a Rs 9 lakh bribery case. India News | Delhi HC Grants Bail to Joint Drug Controller of CDSCO.

Bangalore
Karnataka
India
Patna
Bihar
Delhi
Bengaluru
Odisha
Orissa
New-delhi
Tl-praveen-kumar
Anand-sagar

Delhi HC grants bail to joint drug controller of CDSCO

Delhi HC grants bail to joint drug controller of CDSCO
webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.

Bangalore
Karnataka
India
Patna
Bihar
Delhi
Bengaluru
New-delhi
Tl-praveen-kumar
Dinesh-dua
Biocon-biologics
S-eswara-reddy

vimarsana © 2020. All Rights Reserved.